John D Halpern - Net Worth and Insider Trading

John D Halpern Net Worth

The estimated net worth of John D Halpern is at least $58,652 dollars as of 2025-07-13. John D Halpern is the 10% Owner of Ernexa Therapeutics Inc and owns about 30,078 shares of Ernexa Therapeutics Inc (ERNA) stock worth over $58,652. Details can be seen in John D Halpern's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John D Halpern has not made any transactions after 2022-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of John D Halpern

To

John D Halpern Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John D Halpern owns 1 companies in total, including Ernexa Therapeutics Inc (ERNA) .

Click here to see the complete history of John D Halpern’s form 4 insider trades.

Insider Ownership Summary of John D Halpern

Ticker Company Transaction Date Type of Owner
ERNA Ernexa Therapeutics Inc 2022-12-02 10 percent owner

John D Halpern Latest Holdings Summary

John D Halpern currently owns a total of 1 stock. John D Halpern owns 30,078 shares of Ernexa Therapeutics Inc (ERNA) as of December 2, 2022, with a value of $58,652.

Latest Holdings of John D Halpern

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ERNA Ernexa Therapeutics Inc 2022-12-02 30,078 1.95 58,652

Holding Weightings of John D Halpern


John D Halpern Form 4 Trading Tracker

According to the SEC Form 4 filings, John D Halpern has made a total of 1 transactions in Ernexa Therapeutics Inc (ERNA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Ernexa Therapeutics Inc is the acquisition of 22,395 shares on December 2, 2022, which cost John D Halpern around $1 Million.

Insider Trading History of John D Halpern

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John D Halpern Trading Performance

GuruFocus tracks the stock performance after each of John D Halpern's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John D Halpern is 13.64%. GuruFocus also compares John D Halpern's trading performance to market benchmark return within the same time period. The performance of stocks bought by John D Halpern within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John D Halpern's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John D Halpern

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.42 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.28 LIMIT LIMIT LIMIT LIMIT LIMIT

John D Halpern Ownership Network

Ownership Network List of John D Halpern

No Data

Ownership Network Relation of John D Halpern

Insider Network Chart


John D Halpern Owned Company Details

What does Ernexa Therapeutics Inc do?

Who are the key executives at Ernexa Therapeutics Inc?

John D Halpern is the 10 percent owner of Ernexa Therapeutics Inc. Other key executives at Ernexa Therapeutics Inc include 10 percent owner Charles Cherington , 10 percent owner Freebird Investments Llc , and 10 percent owner Freebird Partners Lp .

Ernexa Therapeutics Inc (ERNA) Insider Trades Summary

Over the past 18 months, John D Halpern made no insider transaction in Ernexa Therapeutics Inc (ERNA). Other recent insider transactions involving Ernexa Therapeutics Inc (ERNA) include a net purchase of 25,009,560 shares made by Charles Cherington ,

In summary, during the past 3 months, insiders sold 0 shares of Ernexa Therapeutics Inc (ERNA) in total and bought 1,416,078 shares, with a net purchase of 1,416,078 shares. During the past 18 months, 0 shares of Ernexa Therapeutics Inc (ERNA) were sold and 1,667,305 shares were bought by its insiders, resulting in a net purchase of 1,667,305 shares.

Ernexa Therapeutics Inc (ERNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ernexa Therapeutics Inc Insider Transactions

No Available Data

John D Halpern Mailing Address

Above is the net worth, insider trading, and ownership report for John D Halpern. Currently GuruFocus does not have mailing address information for John D Halpern.